Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanisms for Intussusception After Rotavirus Vaccine Pilot
NCT02542462Phase 4Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Nov 2015
- Primary completion
- May 2017
- Modality
- Live Attenuated Vaccines, Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of rotavirus vaccine, live, oral and rotavirus vaccine, live, oral, pentavalent in rotavirus infection (4 arms), sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoints: The Effects of RV1 and RV5 With or Without Other Routine Immunizations on Gastrointestinal Anatomy, The Feasibility of Conducting a Larger Scale Study as Determined by Study Recruitment Rates at 15 months and 1 more. Started Nov 2015; status: completed.
02
Drugs
rotavirus vaccine, live, oralrotavirus vaccine, live, oral, pentavalent
03
Conditions
rotavirus infection
Beyond the preview
Go deeper on NCT02542462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02542462.